Medication info

Dongkuk Sitagliptin Tablets 100 mg (Sitagliptin Phosphate Monohydrate)

Prescription medicationTabletOralExpired
Ingredient · strength
Sitagliptin Phosphate Hydrate›128.5mg / 1 tablet
Manufacturer / importer
Dongkuk Pharmaceutical Co., Ltd.
Appearance
Beige round, biconvex film-coated tablet
Packaging
28 tablets/box [(14 tablets/PTP*2)]
Approval status
Expired

MFDS item code 201502396 · Approved 2015.04.22

This product's status changed to Expired on 2025.04.22. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
This medicine is administered at a dose of 100 mg once daily, either as monotherapy or in combination therapy; the maximum daily dose is 100 mg. It may be taken with or without food. When administered in combination with a sulfonylurea or insulin, consider reducing the dose of the sulfonylurea or insulin to reduce the risk of hypoglycemia induced by the sulfonylurea or insulin (see Precautions for Use, 5. General Precautions). Patients with renal impairment Because dose adjustment is required according to renal function, renal function should be assessed before treatment with this medicine and periodically thereafter. 1. No dose adjustment is required in patients with mild renal impairment (glomerular filtration rate [eGFR] ≥ 60mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dose adjustment is required in patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 45mL/min/1.73 m2 and < 60mL/min/1.73 m2). 3. Administer 50 mg once daily to patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 30mL/min/1.73 m2 and < 45mL/min/1.73 m2). 4. Administer 25 mg once daily to patients with severe renal impairment (glomerular filtration rate [eGFR] ≥ 15mL/min/1.73 m2 and < 30mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medicine may be administered regardless of the timing of dialysis.

Ingredients

Manufacturer
Dongkuk Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Difficulty in blood glucose control in patients with type 2 diabetes
View approved original text

This medication is used, along with dietary management and exercise, to assist in blood glucose control for patients with type 2 diabetes. Initially, it can be administered alone, but if the patient has never taken any other diabetes medication and controlling blood sugar is difficult with monotherapy, it is used in conjunction with metformin. Additionally, when blood glucose control is inadequate with monotherapy using sulfonylureas, metformin, thiazolidinediones, or insulin, this medication is added. Furthermore, if the effects of combining these medications are still insufficient, this medication is added to improve therapeutic effects. It is used flexibly in various situations to help better control blood sugar.

How to take

Adult dose

This medicine is administered at a dose of 100 mg once daily, either as monotherapy or in combination therapy; the maximum daily dose is 100 mg. It may be taken with or without food. When administered in combination with a sulfonylurea or insulin, consider reducing the dose of the sulfonylurea or insulin to reduce the risk of hypoglycemia induced by the sulfonylurea or insulin (see Precautions for Use, 5. General Precautions). Patients with renal impairment Because dose adjustment is required according to renal function, renal function should be assessed before treatment with this medicine and periodically thereafter. 1. No dose adjustment is required in patients with mild renal impairment (glomerular filtration rate [eGFR] ≥ 60mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dose adjustment is required in patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 45mL/min/1.73 m2 and < 60mL/min/1.73 m2). 3. Administer 50 mg once daily to patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 30mL/min/1.73 m2 and < 45mL/min/1.73 m2). 4. Administer 25 mg once daily to patients with severe renal impairment (glomerular filtration rate [eGFR] ≥ 15mL/min/1.73 m2 and < 30mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medicine may be administered regardless of the timing of dialysis.

Precautions

This medication may cause severe hypersensitivity reactions after administration; therefore, if allergic symptoms or skin rashes occur, discontinue use immediately and consult a doctor. Additionally, acute pancreatitis has been reported, so if symptoms of pancreatitis such as abdominal pain or vomiting occur, immediate medical attention should be sought. This medication should not be used in patients with type 1 diabetes or diabetic ketoacidosis, and it is also contraindicated in those with allergies to this medication or its components. Patients with impaired kidney function may have increased drug concentration in the blood, necessitating dose adjustments; regular kidney function tests are crucial. Hypoglycemic symptoms may occur while taking this medication, particularly when used in combination with insulin or sulfonylureas, so glucose levels should be monitored closely. Severe joint pain or bullous skin diseases may occur; if these symptoms arise, consult a doctor immediately and consider discontinuing the medication. It is advisable for pregnant or nursing women to avoid using this medication, and safety has not been established for children and adolescents under 18 years of age. In the case of overdose, general supportive measures should be taken, and some medications can be removed through hemodialysis, so treatment should follow medical personnel's instructions if necessary. This medication may interact with some drugs, so inform your doctor or pharmacist if you are taking other medications and follow their guidance. Elderly patients may have a higher chance of kidney function decline, therefore dose adjustments and monitoring of kidney function are needed. If any abnormal symptoms or discomfort occur while taking this medication, it is important to consult with medical personnel for proper action.

Side effects

Severe hypersensitivity reactions, anaphylaxis, angioedema, Stevens-Johnson syndrome, exfoliative dermatitis, acute pancreatitis, hypoglycemia, nasopharyngitis, upper respiratory infection, headache, diarrhea, abdominal pain, nausea, peripheral edema, dyspepsia, dizziness, elevated liver enzyme levels, acute renal failure, constipation, vomiting, joint pain accompanied by severity and disability, bullous pemphigoid, myalgia, limb pain, back pain, interstitial lung disease, pruritus, thrombocytopenia, rhabdomyolysis, pneumonia, diabetes complications, metabolic acidosis, falls, cardiac arrest, increased serum triglycerides, gastritis, weight loss, hypertension, hypernatremia, erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air or moisture from entering. Additionally, avoid storing it in excessively hot or cold places, and it is recommended to store it at room temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

Beige round, biconvex film-coated tablet

Package unit

28 tablets/box [(14 tablets/PTP*2)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.